H5N1 vaccine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "H5N1 vaccine" in English language version.

refsWebsite

Global rank English rank

9fda.gov

447^th place

338^th place

9europa.eu

68^th place

117^th place

4nih.gov

4^th place

3web.archive.org

1^st place

2doi.org

2^nd place

2umn.edu

1,266^th place

860^th place

1canada.ca

1,712^th place

1,063^rd place

1reuters.com

49^th place

47^th place

1harvard.edu

18^th place

17^th place

1scientificamerican.com

896^th place

674^th place

1gov.uk

432^nd place

278^th place

1cslseqirus.co.uk

low place

1fiercepharma.com

low place

8,921^st place

1ansa.it

493^rd place

1,932^nd place

1cslseqirus.us

low place

1biospace.com

low place

7,595^th place

1medscape.com

719^th place

636^th place

1cdc.gov

218^th place

212^th place

1sanofi.us

low place

1zenopa.com

low place

1sinobiological.com

low place

ansa.it

"EU signs maxi contract for avian flu vaccine". Agenzia Nazionale Stampa Associata. 11 June 2024. Archived from the original on 5 January 2025. Retrieved 5 January 2025.

biospace.com

Keown A (4 February 2020). "FDA Approves Seqirus' Audenz as Vaccine Against Potential Flu Pandemic". BioSpace. Retrieved 5 February 2020.

canada.ca

"Health product highlights 2021: Annexes of products approved in 2021". Health Canada. 3 August 2022. Retrieved 25 March 2024.

cdc.gov

CDC (2 October 2024). "Making a Candidate Vaccine Virus (CVV) for a HPAI (Bird Flu) Virus". Avian Influenza (Bird Flu). Retrieved 6 January 2025.

cslseqirus.co.uk

"CSL Seqirus Announces New Pandemic Preparedness Award from the UK Government". www.cslseqirus.co.uk. Retrieved 12 December 2024.

cslseqirus.us

"CSL Seqirus Announces US Government Award in Response to Avian Influenza". CSL Seqirus. 30 May 2024. Retrieved 13 December 2024.

doi.org

Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, et al. (July 2015). "Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody". Proceedings of the National Academy of Sciences of the United States of America. 112 (30): 9430–9435. Bibcode:2015PNAS..112.9430X. doi:10.1073/pnas.1510816112. PMC 4522749. PMID 26170284.{{cite journal}}: CS1 maint: overridden setting (link)
McElwee F, Newall A (July 2024). "The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment". PharmacoEconomics. 42 (Suppl 2): 187–197. doi:10.1007/s40273-024-01396-6. PMC 11230966. PMID 38819720.

europa.eu

ema.europa.eu

"Aflunov EPAR". European Medicines Agency (EMA). 29 November 2010. Retrieved 21 September 2024.
"Vaccines for pandemic influenza". European Medicines Agency. Retrieved 30 July 2024.
"Aflunov EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 13 January 2021.
"Adjupanrix EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 13 January 2021.
"Foclivia EPAR". European Medicines Agency. 17 September 2018. Retrieved 13 January 2021.
"Pumarix EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 13 January 2021.
"Vaccines for pandemic influenza | European Medicines Agency (EMA)". www.ema.europa.eu. Retrieved 13 December 2024.

efsa.europa.eu

"Vaccination of poultry against highly pathogenic avian influenza – Available vaccines and vaccination strategies". efsa.europa.eu. 10 October 2023. Retrieved 9 May 2024.

ec.europa.eu

"Commission secures access for Member States to 665,000 doses of zoonotic influenza vaccines to prevent avian flu". European Commission. 11 June 2024.

fda.gov

"Audenz". U.S. Food and Drug Administration (FDA). 31 January 2020. STN: 125692. Retrieved 5 February 2020. This article incorporates text from this source, which is in the public domain.
"Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted". U.S. Food and Drug Administration. 14 November 2019. Retrieved 21 September 2024.
"Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, manufactured". U.S. Food and Drug Administration. 22 November 2013. Retrieved 21 September 2024.
"Audenz". U.S. Food and Drug Administration (FDA). 31 January 2020. STN: 125692. Archived from the original on 6 August 2020. Retrieved 5 February 2020. This article incorporates text from this source, which is in the public domain.
"FDA Briefing Document - Vaccines and Related Biological Products Advisory Committee Meeting". Food and Drug Administration. 10 October 2024. Retrieved 12 December 2024.
"Package Insert - AUDENZ". US Food and Drug Administration. October 2023. Retrieved 12 December 2024.
"Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, manufactured". U.S. Food and Drug Administration (FDA). 22 November 2013. Retrieved 5 February 2020.
"Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted". U.S. Food and Drug Administration (FDA). 23 April 2019. STN#: 125419. Retrieved 5 February 2020.
Research Cf (25 April 2024). "AUDENZ". FDA.

fiercepharma.com

Liu A (4 October 2024). "GSK, Sanofi, CSL nab BARDA funding for bird flu shots". www.fiercepharma.com. Retrieved 6 January 2025.

gov.uk

"UK secures H5 influenza vaccine to boost pandemic preparedness". GOV.UK. Retrieved 12 December 2024.

harvard.edu

ui.adsabs.harvard.edu

Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, et al. (July 2015). "Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody". Proceedings of the National Academy of Sciences of the United States of America. 112 (30): 9430–9435. Bibcode:2015PNAS..112.9430X. doi:10.1073/pnas.1510816112. PMC 4522749. PMID 26170284.{{cite journal}}: CS1 maint: overridden setting (link)

medscape.com

Lowes R (22 November 2013). "FDA Approves First Adjuvanted Vaccine for H5N1 Bird Flu". Medscape. Retrieved 16 March 2015.

nih.gov

ncbi.nlm.nih.gov

Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, et al. (July 2015). "Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody". Proceedings of the National Academy of Sciences of the United States of America. 112 (30): 9430–9435. Bibcode:2015PNAS..112.9430X. doi:10.1073/pnas.1510816112. PMC 4522749. PMID 26170284.{{cite journal}}: CS1 maint: overridden setting (link)
McElwee F, Newall A (July 2024). "The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment". PharmacoEconomics. 42 (Suppl 2): 187–197. doi:10.1007/s40273-024-01396-6. PMC 11230966. PMID 38819720.

pubmed.ncbi.nlm.nih.gov

Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, et al. (July 2015). "Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody". Proceedings of the National Academy of Sciences of the United States of America. 112 (30): 9430–9435. Bibcode:2015PNAS..112.9430X. doi:10.1073/pnas.1510816112. PMC 4522749. PMID 26170284.{{cite journal}}: CS1 maint: overridden setting (link)
McElwee F, Newall A (July 2024). "The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment". PharmacoEconomics. 42 (Suppl 2): 187–197. doi:10.1007/s40273-024-01396-6. PMC 11230966. PMID 38819720.

reuters.com

"Bird flu vaccination policies by country". Reuters. 17 February 2023. Retrieved 30 July 2024.

sanofi.us

news.sanofi.us

"FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza". Sanofi US News. April 2007. Retrieved 7 January 2025.

scientificamerican.com

Fox M. "We May Not Have Enough Bird Flu Vaccines when We Need Them". Scientific American. Retrieved 12 December 2024.

sinobiological.com

"H5N1 Influenza Pandemic Threat (Avian Flu) | Sino Biological". www.sinobiological.com. Archived from the original on 12 September 2024. Retrieved 13 December 2024.

umn.edu

cidrap.umn.edu

"UK orders H5 avian flu vaccine for pandemic preparedness | CIDRAP". www.cidrap.umn.edu. 3 December 2024. Retrieved 12 December 2024.
"Australia approves CSL's H5N1 vaccine | CIDRAP". www.cidrap.umn.edu. 17 June 2008. Retrieved 7 January 2025.

web.archive.org

"Audenz". U.S. Food and Drug Administration (FDA). 31 January 2020. STN: 125692. Archived from the original on 6 August 2020. Retrieved 5 February 2020. This article incorporates text from this source, which is in the public domain.
"EU signs maxi contract for avian flu vaccine". Agenzia Nazionale Stampa Associata. 11 June 2024. Archived from the original on 5 January 2025. Retrieved 5 January 2025.
"H5N1 Influenza Pandemic Threat (Avian Flu) | Sino Biological". www.sinobiological.com. Archived from the original on 12 September 2024. Retrieved 13 December 2024.

zenopa.com

"GSK announces first EU authorisation for Prepandrix - Industry News - Zenopa UK". Zenopa. 20 May 2008. Retrieved 7 January 2025.